Arcus Biosciences, Inc.

RCUS US Health Care Biotechnology
S&P 600
$24.59
-5.97%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Arcus Biosciences, Inc. belong to?
Arcus Biosciences, Inc. operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of RCUS?
As of the latest available quote, RCUS traded at $24.59. This price is delayed and cached for about 15 minutes.
What is the market capitalisation of RCUS?
The market capitalisation of Arcus Biosciences, Inc. is approximately $2.64B.
Is Arcus Biosciences, Inc. profitable?
For its latest reported financial year, Arcus Biosciences, Inc. recorded a negative net profit margin of about -1,069.70% (a net loss for the latest period).
Does RCUS pay a dividend?
Arcus Biosciences, Inc. does not currently show a dividend yield in our data.
What is the return on equity (ROE) of RCUS?
Arcus Biosciences, Inc. has a return on equity (ROE) of about -76.08%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of RCUS?
Over the past 52 weeks, RCUS has traded between a low of $11.30 and a high of $31.74.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.